Algo version: 0.98b
Greenyn Biotechnology Co is listed at the TWO Exchange
Greenyn Biotechnology Co [6846.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is Greenyn Biotechnology Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Greenyn Biotechnology Co pays dividends. Last time was Wednesday 19th of June 2024 where the investors holding the stock on Monday 27th of May 2024 were paid TWD3.49595 per share. Over the last 2 times between 2023 and 2024, Greenyn Biotechnology Co has paid TWD7.39595 with an average of TWD3.7 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Greenyn Biotechnology Co 10 years ago, but if you had invested on Tuesday 19th of April 2022 when the price was TWD88.20, you would have made a loss of TWD-12.30 per share or -13.95%

Yes, the average daily trading liquidity for Greenyn Biotechnology Co is TWD21 516 thousand. You should therefore be able to get in and out of your positions relatively fast.

Greenyn Biotechnology Co has no real debt, which is good in periods of high inflation. Greenyn Biotechnology Co has a good net profit margin of 15.66% and should have high tolerances against inflation.

We have calculated the inflation risk for Greenyn Biotechnology Co to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.